# Cytopathology of Thoracic SMARCA4-Deficient Undifferentiated Tumor: A Case Report

**Authors:** Thomas Harrington, Katsiaryna Khatskevich, Jessica A Forcucci, Jack Yang, Travis Ferguson, Hao Liu

PMC · DOI: 10.7759/cureus.82798 · Cureus · 2025-04-22

## TL;DR

This case report describes a rare aggressive tumor called thoracic SMARCA4-deficient undifferentiated tumor, diagnosed through cytopathology in a patient with a minimal smoking history.

## Contribution

The report provides a detailed cytopathological description of a rare SMARCA4-deficient undifferentiated tumor case, emphasizing diagnostic challenges and immunohistochemical findings.

## Key findings

- The tumor was diagnosed via FNA cytology showing two populations of malignant cells with necro-inflammatory debris.
- Immunohistochemistry showed patchy positivity for INSM-1 and PAX-8 but negativity for keratin markers and TTF-1.
- Loss of SMARCA4 (BRG1) expression confirmed the diagnosis of SMARCA4-deficient undifferentiated tumor.

## Abstract

Thoracic SMARCA4-deficient undifferentiated tumor (SMARCA4-UT) is an aggressive tumor with a dismal prognosis, most commonly involving the mediastinum and lungs. The diagnosis of SMARCA4-UT is still challenging, both clinically and pathologically, due to its non-specific clinical findings, a broad list of differential diagnoses, and rarity of cases reported in the literature, especially in terms of cytopathology. Most patients present at an advanced stage of disease at the time of diagnosis, and fine needle aspiration (FNA) cytology specimens and/or core biopsies are often the only diagnostic material available. SMARCA4-UT tumors are strongly associated with a smoking history; however, approximately 10% of the patients are never smokers. We report a case of a 78-year-old male with a remote minimal smoking history who presented with a large mediastinal mass and hilar lymphadenopathy. FNA of the mass demonstrated a moderately cellular aspirate with two populations of loosely cohesive malignant cells in a background of necro-inflammatory debris and bare nuclei. The majority of malignant cells showed enlarged nuclei with prominent nucleoli and scant cytoplasm, with a few malignant cells showing rhabdoid features. Immunohistochemical staining of the cell block showed the malignant cells were patchy positive for INSM-1 and PAX-8; however, negative for keratin markers, TTF-1, Napsin A, and p40. SMARCA4-UT was diagnosed with the loss of SMARCA4 (BRG1) expression in the tumor cells.

## Linked entities

- **Genes:** SMARCA4 (SWI/SNF related BAF chromatin remodeling complex subunit ATPase 4) [NCBI Gene 6597], SMARCA4 (SWI/SNF related BAF chromatin remodeling complex subunit ATPase 4) [NCBI Gene 6597], INSM1 (INSM transcriptional repressor 1) [NCBI Gene 3642], PAX8 (paired box 8) [NCBI Gene 7849], TTF1 (transcription termination factor 1) [NCBI Gene 7270], Napsa (napsin A aspartic peptidase) [NCBI Gene 101706612], IL9 (interleukin 9) [NCBI Gene 3578]

## Full-text entities

- **Genes:** IL9 (interleukin 9) [NCBI Gene 3578] {aka HP40, IL-9, P40}, PAX8 (paired box 8) [NCBI Gene 7849] {aka PAX-8}, TTF1 (transcription termination factor 1) [NCBI Gene 7270] {aka TTF-1, TTF-I}, SMARCA4 (SWI/SNF related BAF chromatin remodeling complex subunit ATPase 4) [NCBI Gene 6597] {aka BAF190, BAF190A, BRG1, CSS4, MRD16, OTSC12}, INSM1 (INSM transcriptional repressor 1) [NCBI Gene 3642] {aka IA-1, IA1}, NAPSA (napsin A aspartic peptidase) [NCBI Gene 9476] {aka KAP, Kdap, NAP1, NAPA, NR1H2-AS1, SNAPA}
- **Diseases:** lymphadenopathy (MESH:D008206), tumor (MESH:D009369), Undifferentiated Tumor (MESH:D002277)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12097722/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12097722/full.md

## References

12 references — full list in the complete paper: https://tomesphere.com/paper/PMC12097722/full.md

---
Source: https://tomesphere.com/paper/PMC12097722